North America Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity
North America Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity
North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technological advancements, and a rising number of new drug production and launches.
Highlighted with 29 tables and 57 figures, this 126-page report “North America Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire North America bioprocess technology market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America bioprocess technology market in every aspect of the classification from perspectives of Product, Process, Procedure, Application, End User, and Country.
Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Instruments
o Bioprocess Analyzers
o Osmometers
o Bioreactors
o Incubators
o Other Instruments
• Consumables and Accessories
o Culture Media
o Reagents
o Other Consumables and Accessories
Based on Process, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Upstream Bioprocessing
• Downstream Bioprocessing
By Procedure, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Cell Culture
• Cell Expansion
• Flow Cytometry
• Cell Line Development
• Cell Counting
• Biologics Safety Testing
• Tangential Flow Filtration (TFF)
• Other Procedures
By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Recombinant Proteins
• Antibiotics
• Biosimilars
• Monoclonal Antibodies (mAbs)
• Other Applications
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Academic Research Institutes
• Contract Research Organizations (CROs)
• Food & Feed Industry
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2023-2033. The breakdown of national markets by Product, Application, and End User over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Advanced Instruments LLC
Agilent Technologies, Inc.
Becton Dickinson and Company
Bio-rad Laboratories Inc.
Boehringer Ingelheim International GmbH
Catalent Inc.
Charles River Laboratories
Corning Inc.
Danaher Corporation
Elitechgroup Inc. (gonotec Gmbh)
Eppendorf Se
F. Hoffmann-la Roche Ltd.
Fujifilm Healthcare Americas Corporation
GE Healthcare (General Electric Company)
Getinge Ab
Koninklijke Philips N.V.
Lonza Group Ag
Merck Kgaa
Repligen Corp.
Sartorius Group
STADA Arzneimittel AG
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.1.3 Impact of Russia-Ukraine Conflict 26
2.1.4 Impact of Israel-Palestine War 28
2.2 Major Growth Drivers 29
2.3 Market Restraints and Challenges 34
2.4 Emerging Opportunities and Market Trends 37
2.5 Porter’s Fiver Forces Analysis 41
3 Segmentation of North America Market by Product 45
3.1 Market Overview by Product 45
3.2 Instruments 47
3.2.1 Bioprocess Analyzers 49
3.2.2 Osmometers 50
3.2.3 Bioreactors 51
3.2.4 Incubators 52
3.2.5 Other Instruments 53
3.3 Consumables and Accessories 54
3.3.1 Culture Media 56
3.3.2 Reagents 57
3.3.3 Other Consumables and Accessories 58
4 Segmentation of North America Market by Process 59
4.1 Market Overview by Process 59
4.2 Upstream Bioprocessing 61
4.3 Downstream Bioprocessing 62
5 Segmentation of North America Market by Procedure 63
5.1 Market Overview by Procedure 63
5.2 Cell Culture 65
5.3 Cell Expansion 66
5.4 Flow Cytometry 67
5.5 Cell Line Development 68
5.6 Cell Counting 69
5.7 Biologics Safety Testing 70
5.8 Tangential Flow Filtration (TFF) 71
5.9 Other Procedures 72
6 Segmentation of North America Market by Application 73
6.1 Market Overview by Application 73
6.2 Recombinant Proteins 75
6.3 Antibiotics 76
6.4 Biosimilars 77
6.5 Monoclonal Antibodies (mAbs) 78
6.6 Other Applications 79
7 Segmentation of North America Market by End User 80
7.1 Market Overview by End User 80
7.2 Biopharmaceutical Companies 82
7.3 Contract Manufacturing Organizations (CMOs) 83
7.4 Academic Research Institutes 84
7.5 Contract Research Organizations (CROs) 85
7.6 Food & Feed Industry 86
7.7 Other End Users 87
8 North America Market 2023-2033 by Country 88
8.1 Overview of North America Market 88
8.2 U.S. 91
8.3 Canada 94
8.4 Mexico 96
9 Competitive Landscape 98
9.1 Overview of Key Vendors 98
9.2 New Product Launch, Partnership, Investment, and M&A 102
9.3 Company Profiles 103
Advanced Instruments LLC 103
Agilent Technologies, Inc. 105
Becton Dickinson and Company 106
Bio-rad Laboratories Inc. 107
Boehringer Ingelheim International GmbH 108
Catalent Inc. 109
Charles River Laboratories 110
Corning Inc. 111
Danaher Corporation 112
Elitechgroup Inc. (gonotec Gmbh) 113
Eppendorf Se 114
F. Hoffmann-la Roche Ltd. 115
Fujifilm Healthcare Americas Corporation 116
GE Healthcare (General Electric Company) 117
Getinge Ab 118
Koninklijke Philips N.V. 119
Lonza Group Ag 120
Merck Kgaa 121
Repligen Corp. 122
Sartorius Group 123
STADA Arzneimittel AG 124
Thermo Fisher Scientific Inc. 125
RELATED REPORTS 126
List of Tables:
Table 1. Snapshot of North America Bioprocess Technology Market in Balanced Perspective, 2023-2033 17
Table 2. World Economic Outlook, 2024-2036 21
Table 3. World Economic Outlook, 2022-2024 23
Table 4. Scenarios for Economic Impact of Ukraine Crisis 27
Table 5. Scenarios for Economic Impact of Israel-Palestine War 28
Table 6. Estimated Worldwide Spending on Biopharmaceutical R&D, 2015-2023, $ billion 32
Table 7. World Health Spending by Region, $ bn, 2013-2020 33
Table 8. Main Product Trends and Market Opportunities in North America Bioprocess Technology Market 37
Table 9. North America Bioprocess Technology Market by Product, 2023-2033, $ mn 45
Table 10. North America Bioprocess Technology Market: Instruments by Type, 2023-2033, $ mn 48
Table 11. North America Bioprocess Technology Market: Consumables and Accessories by Type, 2023-2033, $ mn 55
Table 12. North America Bioprocess Technology Market by Process, 2023-2033, $ mn 59
Table 13. North America Bioprocess Technology Market by Procedure, 2023-2033, $ mn 63
Table 14. North America Bioprocess Technology Market by Application, 2023-2033, $ mn 73
Table 15. North America Bioprocess Technology Market by End User, 2023-2033, $ mn 80
Table 16. North America Bioprocess Technology Market by Country, 2023-2033, $ mn 89
Table 17. U.S. Bioprocess Technology Market by Product, 2023-2033, $ mn 93
Table 18. U.S. Bioprocess Technology Market by Application, 2023-2033, $ mn 93
Table 19. U.S. Bioprocess Technology Market by End User, 2023-2033, $ mn 93
Table 20. Canada Bioprocess Technology Market by Product, 2023-2033, $ mn 95
Table 21. Canada Bioprocess Technology Market by Application, 2023-2033, $ mn 95
Table 22. Canada Bioprocess Technology Market by End User, 2023-2033, $ mn 95
Table 23. Mexico Bioprocess Technology Market by Product, 2023-2033, $ mn 97
Table 24. Mexico Bioprocess Technology Market by Application, 2023-2033, $ mn 97
Table 25. Mexico Bioprocess Technology Market by End User, 2023-2033, $ mn 97
Table 26. Key Vendors and Their Product Offerings 100
Table 27. Advanced Instruments LLC: Company Snapshot 103
Table 28. Advanced Instruments LLC: Business Segmentation 104
Table 29. Advanced Instruments LLC: Product Portfolio 104
List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033 16
Figure 4. North America Bioprocess Technology Market, 2023-2033, $ mn 19
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of North America Bioprocess Technology Market 29
Figure 7. World Population 65 and Over, % of Total Population, 1950-2060 32
Figure 8. Primary Restraints and Impact Factors of North America Bioprocess Technology Market 34
Figure 9. Investment Opportunity Analysis 38
Figure 10. Porter’s Fiver Forces Analysis of North America Bioprocess Technology Market 41
Figure 11. Breakdown of North America Bioprocess Technology Market by Product, 2023-2033, % of Revenue 46
Figure 12. North America Addressable Market Cap in 2024-2033 by Product, Value ($ mn) and Share (%) 46
Figure 13. North America Bioprocess Technology Market by Product: Instruments, 2023-2033, $ mn 47
Figure 14. North America Bioprocess Technology Market by Instruments: Bioprocess Analyzers, 2023-2033, $ mn 49
Figure 15. North America Bioprocess Technology Market by Instruments: Osmometers, 2023-2033, $ mn 50
Figure 16. North America Bioprocess Technology Market by Instruments: Bioreactors, 2023-2033, $ mn 51
Figure 17. North America Bioprocess Technology Market by Instruments: Incubators, 2023-2033, $ mn 52
Figure 18. North America Bioprocess Technology Market by Instruments: Other Instruments, 2023-2033, $ mn 53
Figure 19. North America Bioprocess Technology Market by Product: Consumables and Accessories, 2023-2033, $ mn 54
Figure 20. North America Bioprocess Technology Market by Consumables and Accessories: Culture Media, 2023-2033, $ mn 56
Figure 21. North America Bioprocess Technology Market by Consumables and Accessories: Reagents, 2023-2033, $ mn 57
Figure 22. North America Bioprocess Technology Market by Consumables and Accessories: Other Consumables and Accessories, 2023-2033, $ mn 58
Figure 23. Breakdown of North America Bioprocess Technology Market by Process, 2023-2033, % of Sales Revenue 60
Figure 24. North America Addressable Market Cap in 2024-2033 by Process, Value ($ mn) and Share (%) 60
Figure 25. North America Bioprocess Technology Market by Process: Upstream Bioprocessing, 2023-2033, $ mn 61
Figure 26. North America Bioprocess Technology Market by Process: Downstream Bioprocessing, 2023-2033, $ mn 62
Figure 27. Breakdown of North America Bioprocess Technology Market by Procedure, 2023-2033, % of Sales Revenue 64
Figure 28. North America Addressable Market Cap in 2024-2033 by Procedure, Value ($ mn) and Share (%) 64
Figure 29. North America Bioprocess Technology Market by Procedure: Cell Culture, 2023-2033, $ mn 65
Figure 30. North America Bioprocess Technology Market by Procedure: Cell Expansion, 2023-2033, $ mn 66
Figure 31. North America Bioprocess Technology Market by Procedure: Flow Cytometry, 2023-2033, $ mn 67
Figure 32. North America Bioprocess Technology Market by Procedure: Cell Line Development, 2023-2033, $ mn 68
Figure 33. North America Bioprocess Technology Market by Procedure: Cell Counting, 2023-2033, $ mn 69
Figure 34. North America Bioprocess Technology Market by Procedure: Biologics Safety Testing, 2023-2033, $ mn 70
Figure 35. North America Bioprocess Technology Market by Procedure: Tangential Flow Filtration (TFF), 2023-2033, $ mn 71
Figure 36. North America Bioprocess Technology Market by Procedure: Other Procedures, 2023-2033, $ mn 72
Figure 37. Breakdown of North America Bioprocess Technology Market by Application, 2023-2033, % of Revenue 74
Figure 38. North America Addressable Market Cap in 2024-2033 by Application, Value ($ mn) and Share (%) 74
Figure 39. North America Bioprocess Technology Market by Application: Recombinant Proteins, 2023-2033, $ mn 75
Figure 40. North America Bioprocess Technology Market by Application: Antibiotics, 2023-2033, $ mn 76
Figure 41. North America Bioprocess Technology Market by Application: Biosimilars, 2023-2033, $ mn 77
Figure 42. North America Bioprocess Technology Market by Application: Monoclonal Antibodies (mAbs), 2023-2033, $ mn 78
Figure 43. North America Bioprocess Technology Market by Application: Other Applications, 2023-2033, $ mn 79
Figure 44. Breakdown of North America Bioprocess Technology Market by End User, 2023-2033, % of Revenue 81
Figure 45. North America Addressable Market Cap in 2024-2033 by End User, Value ($ mn) and Share (%) 81
Figure 46. North America Bioprocess Technology Market by End User: Biopharmaceutical Companies, 2023-2033, $ mn 82
Figure 47. North America Bioprocess Technology Market by End User: Contract Manufacturing Organizations (CMOs), 2023-2033, $ mn 83
Figure 48. North America Bioprocess Technology Market by End User: Academic Research Institutes, 2023-2033, $ mn 84
Figure 49. North America Bioprocess Technology Market by End User: Contract Research Organizations (CROs), 2023-2033, $ mn 85
Figure 50. North America Bioprocess Technology Market by End User: Food & Feed Industry, 2023-2033, $ mn 86
Figure 51. North America Bioprocess Technology Market by End User: Other End Users, 2023-2033, $ mn 87
Figure 52. Breakdown of North America Bioprocess Technology Market by Country, 2023 and 2033, % of Revenue 89
Figure 53. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 90
Figure 54. U.S. Bioprocess Technology Market, 2023-2033, $ mn 92
Figure 55. Canada Bioprocess Technology Market, 2023-2033, $ mn 94
Figure 56. Bioprocess Technology Market in Mexico, 2023-2033, $ mn 96
Figure 57. Growth Stage of North America Bioprocess Technology Industry over the Forecast Period 98
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|